HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

UH-A 46 XX

structure given in first source

Also Known As:

4-hydroxy-2-methyl-N-(4-methyl-2-pyridyl)-2H-naphtho(2,1-e)-1,2-thiazine-3-carboxamide-1,1-dioxide; UH-A-46-XX

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Sulfur Compounds: 278
  - Thiazines: 3
    - Piroxicam: 1149
      - UH-A 46 XX: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Thiazines: 3
    - Piroxicam: 1149
      - UH-A 46 XX: 1

Related Diseases

1.	Pancytopenia 01/01/1990 - "The pathogenesis of pancytopenia caused by UH-A 46 XX seems to be a chemically induced hyperdestruction of the peripheral blood cells. " 01/01/1990 - "During subacute and chronic toxicity studies on beagle dogs with the platelet aggregation inhibitor UH-A 46 XX, a suboxicam derivative, a pancytopenia of the peripheral blood with granulocytopoietic bone marrow hyperplasia was induced. "
2.	Hyperplasia 01/01/1990 - "During subacute and chronic toxicity studies on beagle dogs with the platelet aggregation inhibitor UH-A 46 XX, a suboxicam derivative, a pancytopenia of the peripheral blood with granulocytopoietic bone marrow hyperplasia was induced. "
3.	Fever (Fevers) 01/01/1990 - "As early as the 8th week, but mostly between the 9th and 12th experimental weeks, one third of the animals treated orally with 700 mg/kg b.wt. UH-A 46 XX per day developed an acute fever (10 out of 30 animals). "

Related Drugs and Biologics

1.	Platelet Aggregation Inhibitors (Antiplatelet Drugs)